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Objective. To report the long term results of ultrasonic superficial femoral artery endarterectomy (USFAE).
Design. Retrospective study.
Patients and methods. From January 1998 to June 2004 218 USFAE were performed in 202 selected patients (178 males,
192 procedures) with a median age of 65 years (46-87 years). Indications for operation were disabling intermittent clau-
dication in 137 procedures (68%), rest pain in 24 procedures (12%), and limb salvage in 41 procedures (20%). The new
medical technology of ultrasonic endarterectomy is based on the application of the mechanical vibrations in the range of low
frequency ultrasound. The ultrasonic device consists of the ultrasonic generator, acoustic unit and the flexible wave con-
centrators with special working tips in the shape of a ring. Follow up consisted of clinical evaluation, ankle-brachial index
measurements and duplex scanning.
Results. The mean follow-up time was 30.1 months. The mean length of the endarterectomised SFAs was 29 cm (range,
15e43 cm). The five year cumulative primary patency rate by means of life table analysis was 45.8 4.4% (SE). Percu-
taneous transluminal balloon angioplasty and surgical re-interventions were performed in thirty three and five patients
respectively resulting in a primary assisted patency rate of 57.5 4.1%. The five year secondary patency rate was
65.6 3.8%. Limb salvage was achieved in 35 of the 41 patients with gangrene.
Conclusions. The long term results of ultrasonic SFA endarterectomy suggest this is an effective technique.
Keywords: Ultrasonic endarterectomy; Superficial femoral artery; Peripheral arterial occlusive disease; Intermittent
claudication.Introduction
The surgical treatment of superficial femoral artery
(SFA) occlusions is a challenging field in vascular sur-
gery. The first choice treatment of long segmental SFA
occlusions is venous above-knee (ABK) bypass graft-
ing which offers a 5 year primary patency of up to
73%.1 There are several situations in which alternative
treatment options are indicated, such as patients in
which the great saphenous vein has been previously
harvested.
The first thromboendarterectomy through two arte-
riotomies was performed by Cid dos Santos in 1946.2
During the past 6 decades several different methods
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percutaneous transluminal angioplasty (PTA), sub-
intimal angioplasty, oscillating loop endarterectomy
and remote endarterectomy (RSFAE).3e6 Despite the
high initial technical success rate of PTA, long-term
results are disappointing particularly for long occlu-
sions.7,8 Stent placement has not resulted in improved
patency.9,10 Subintimal angioplasty is feasible and
can be effective in high risk patients, although the
long-term results are poor.11,12 RSFAE is a minimal
invasive endovascular procedure. It has been exten-
sively described by various vascular surgeons with
5-year primary assisted patency rates similar to pros-
thetic ABK bypass surgery.13e17
Our vascular surgery department has been per-
forming ultrasonic endarterectomies using flexible
ultrasonic instruments since January 1998.18 It is min-
imally invasive and generally avoids a second proxi-
mal incision. It also avoids the use of prostheticrved.
658 A. V. Pokrovsky et al.graft material and can be used in the absence of the
saphenous vein, preserving it for future coronary
surgery.
The purpose of this study is to report the long term
results of ultrasonic superficial femoral artery endar-
terectomy (USFAE), performed with flexible ultra-
sonic instruments, and to determine its place in the
armamentarium of the vascular surgeon in the treat-
ment of long segmental SFA occlusive disease.
Materials and Methods
Patients
Two hundred eighteen USFAE procedures were
performed in 202 patients from January 1998 to
June 2004. All operations were performed in the
N. Semashko hospital Moscow, Russia. Enrolment of
patients was equally spread over the years. Ruther-
ford classification was used to assess the stage of
ischemia.19 When intermittent claudication was diag-
nosed at the first visit, conservative treatment was
established, including walking exercise, cessation of
smoking, and antiplatelet drugs. If the conservative
treatment was unsuccessful, the patients were sched-
uled for an USFAE after 3 months. The study was
approved by the local ethics committee and written
informed consent was obtained. Preoperative evalua-
tion included ankle-brachial pressure indices, colour
flow duplex scanning, and angiography. All patients
suffered from SFA long segmental occlusion and
had a patent popliteal artery with at least one crural
runoff vessel.
Technique of the USFAE procedure
The new highly effective medical technology of ultra-
sonic endarterectomy is based on the application of
mechanical vibrations in the range of low frequency
ultrasound (Fig. 1). The ultrasonic device consists of
the ultrasonic generator (USG), acoustic unit (AU),
which serves as a handle for the surgeon, and flexible
wave concentrators with special working tips in the
shape of a ring. The rings come in different sizes,
ranging from 4 to 10 millimeters in inner diameter.
The generator is the source of the electrical ultrasonic
vibrations. It is used to transform the sinusoidal elec-
trical low frequency signal (50 Hz) into electrical ul-
trasonic signal (26 kHz). The generator is electrically
connected with the acoustic unit converting electro-
magnetic vibrations into mechanical energy of the
same frequency at an amplitude 40 microns. The flex-
ibility of the endarterectomy instruments allows themEur J Vasc Endovasc Surg Vol 32, December 2006to be passed along the length of the SFA (Fig. 2). Due to
the ultrasonic vibrations applied, less effort is required
to separate the layers of the artery. The facilitation of
the separation of layers is explained by two major
effects: vibroshock and hydrodynamic phenomenon.
Due to the ultrasonic vibrations, the instrument moves
smoothly and swiftly inside the artery, the surgeon
needing to apply less force. This considerably reduces
the danger of wall perforation. The hydrodynamic
effect caused by the presence of the biological liquid
in the artery wall also facilitates the separation effort.
This effect can be strengthened by supplying physio-
logical solution into the ultrasonic operation zone.
The popliteal artery is exposed through a standard
incision above the knee Distal to the occlusion. The
Fig. 1. General view of the ultrasonic device for
endarterectomy.
Fig. 2. Ultrasonic endarterectomy technique.
659Technique and Results of Ultrasonic SFA Endarterectomydistal segment of artery is heparinized with a diluted
heparin-saline solution and the distal popliteal artery
is cross-clamped. The distal intima is tacked down
with a 6-0 Prolene suture. The occluding core is mobi-
lized with a small elevator. The original instrument
ring is passed proximally up the SFA and the occlud-
ing core is removed from the artery. If the proximal
intimal core is not completely removed, a second
incision is made to carry out a common femoral
endarterectomy. If needed a profundoplasty can be
performed.
In order to avoid arterial penetrationblunt and sharp
edgesweredeveloped in the ring of the endarterectomy
device (Fig. 3). When the blunt side of the ring contacts
atheroma at a side branch resistance to progress of the
instrument is felt (Fig. 3a). In this case the instrument
should be gently retracted and rotated along the longi-
tudinal axis with subsequent forward movement
(Fig. 3b). This techniques allow safe passage of the end-
arterectomydevice (Fig. 3c). Finally, a FogartyThrom-
bectomy Catheter (Pan medical limited, England) is
passed along thewhole SFA in order to remove residual
debris. The arteriotomy is closed by a vein patch sewn
in with a 6-0 Prolene. The procedure takes approxi-
mately 60 minutes to complete.
Fig. 3. Encountering with collateral branches.After the procedure, outpatient examinations were
performed at 4 weeks, 8 weeks and every 3 months for
1 year, and then annually. Routine surveillance con-
sisted of colour-flow duplex scanning in the depart-
ment of radiology (Toshiba Applio model SSA-770A,
Fundamentals 2B 730-595 E*J, Japan). Clinical and
haemodynamic results were evaluated by recurrent
symptoms and ankle-brachial blood pressure index
measurements at every follow-up visit. All patients
were placed on antiplatelet agents, i.e. aspirin at the
surgeon’s discretion.Adversepatient outcomes includ-
ing wound complications, re-stenosis or re-occlusion
and major amputation were recorded. Primary pa-
tency is defined as uninterrupted patency of the
treated artery or its anastomoses without any further
procedures. If PTA was necessary to prevent occlu-
sion, the artery was classified as assisted primary
patency. In the event arterial flow was restored by
thrombectomy or by-pass procedure after an occlu-
sion, the patency was classified as secondary. The de-
cision for reintervention was made on the basis of
the combination of recurrent clinical symptoms, re-
duced ankle-brachial indices, and restenoses seen
on duplex scanning or angiography.
Statistical methods
Statistical analysis was performed by using the com-
puter software programs SPSS/w 12.0 (Statistical
Package for Social Sciences 12.0 for Windows, Inc.,
Chicago, IL, USA). Data are presented as real numbers
(percentages), median (minimum-maximum), mean
values and standard deviations (SD). Life table analy-
sis was used to evaluate cumulative patency and
survival rates. A p-value <0.05 was considered to
indicate statistical significance.
Results
Two hundred and eighteen consecutive limbs in 202
patients underwent a successful ultrasonic endart-
erectomy. The median age (range) was 65 years
(46e87 years). One hundred seventy eight patients
were males (192 procedures) and 24 were females
(26 procedures). The indications for surgical interven-
tion were disabling intermittent claudication in 137
(68%) procedures (Rutherford category 3), rest pain
in 24 (12%) procedures (Rutherford category 4), and
gangrene of the toes in 41 (20%) procedures (Ruther-
ford category 5). Thirty five patients had a medical
history of previous peripheral vascular interventions.
12 patients had undergone an intervention within the
ipsilateral femoro-popliteal segment. Other previousEur J Vasc Endovasc Surg Vol 32, December 2006
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PTA (4), PTA with stent placement (1), and femoral
profundoplasty (2). Twenty three patients had pre-
viously undergone other peripheral vascular inter-
ventions including aorto-biiliac bypass (6), PTA of
ipsilateral iliac artery (10), PTA in the contralateral
SFA (7). In 97% of all cases the SFA was occluded, of
which 75% extended over more than half of the
femoro-popliteal segment. In 179 (82%) cases there
were two or three runoff arteries and in 39 (18%) cases
there was single artery runoff. In 26 (12%) cases there
was no suitable vein in the leg.
Technical and procedural success
The mean length (range) of the endarterectomised
segment of SFA was 29 cm (15e43 cm). The intima
core was usually removed in one piece. Postoperative
complications, that needed additional treatment, were
haematoma in five (2.4%) cases and wound infection
in seven (3.2%) patients. In four patients the superfi-
cial femoral artery was perforated during endarterec-
tomy. These patients all underwent successful
femoropopliteal bypass under the same anesthetic.
Two patients died as a result of a myocardial infarc-
tion within 30 days after the operation. The median
ankle-brachial index improved from 0.50 (0.12)
preoperative to 0.94 (0.12) postoperative. Clinical
improvement of at least one stage, according to the
SVS/ISCVS criteria, was achieved in all patients.
Long-term follow up
Median follow-up time was 30.1 months with a range
from 1 to 84 months. Life table analysis shows a 1 and
5 year patient survival rate of 96.7 and 80.4%, respec-
tively. The 5 year cumulative primary patency rate by
means of life-table analysis was 45.8  4.4% (SE)
(Fig. 4, Table 1). Five year primary assisted patency
rate was 57.5  4.1%. Percutaneous transluminal bal-
loon (31) and stent (2) angioplasty were performed
in 33 patients (Fig. 4, Table 2), and surgical revisionEur J Vasc Endovasc Surg Vol 32, December 2006of the proximal and distal SFA was performed in
one and four patients, respectively. The five-year
secondary patency rate was 65.6 3.8%, after embo-
lectomy (4), fibrinolysis with actilyse (2) and grafting
(14) (Table 3). In six of the 41 patients presented with
gangrene of the toes four above-knee amputations
and two below-knee amputations were performed.
Discussion
The effects of ultrasound energy on femoral artery
occlusion were described by Drobinski G et al. In 10
patients with SFA occlusions the authors used an
ultrasonic angioplastic technique developed by the
group. The study shows that ultrasonic angioplasty
is capable of recanalizing an occlusion of SFA with
partial or total disruption of thrombi.20
The ultrasonic endarterectomy offers a new safe
and effective treatment of long segmental SFA
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Fig. 4. Cumulative primary, primary assisted and secondary
patency after ultrasonic superficial femoral artery endarter-
ectomy by life table method.Table 1. Life table data of primary patency rate
Interval start
time (years)
Number
entering
interval
Withdrawing
during interval
Number
exposed
to risk
Number of
terminal events
Failure
rate, %
Cumulative
patency, %
Std. error of
cumulative
patency, %
0 218 15 210.5 16 7.6 92.4 1.8
1 187 17 178.5 20 11.2 82.0 2.7
2 150 17 141.5 27 19.1 66.4 3.5
3 106 25 93.5 16 17.1 55.0 3.9
4 65 35 47.5 8 16.8 45.8 4.4
5 22 22 11 0 0.0 45.8 4.4
661Technique and Results of Ultrasonic SFA EndarterectomyTable 2. Life table data of primary e assisted patency rate
Interval start
time (years)
Number
entering
interval
Withdrawing
during interval
Number
exposed to
risk
Number of
terminal
events
Failure
rate, %
Cumulative
patency, %
Std. error of
cumulative
patency, %
0 218 15 210.5 14 6.7 93.3 1.7
1 189 17 180.5 18 10.0 84.0 2.6
2 154 17 145.5 22 15.1 71.3 3.3
3 115 25 102.5 11 10.7 63.7 3.7
4 79 35 61.5 6 9.8 57.5 4.1
5 38 38 19 0 0.0 57.5 4.1occlusive disease. Previous operations in the ipsilat-
eral SFA, are not necessarily a contraindication.
In USFAE the whole intima core is removed and
a complete disobliteration of the SFA is performed.
Perforation of the SFA is one of the intraoperative
complications that can occur during the operation.
In four cases of SFA perforation the superficial femo-
ral artery was heavily calcified. These limbs all under-
went successful standard above knee prosthetic
bypass. Lerwick, Galland et al., Smeets et al. describe
similar SFA perforation during oscillating loop endar-
terectomy and RSFAE.5,13,15 Superficial femoral artery
endarterectomy can be performed by open, semi-
closed, remote or ultrasonic techniques. Published
results of SFA endarterectomy are sometimes difficult
to interpret due to the heterogenous nature of the
lesions treated.21 Following SFA endarterectomy 1
and 5 year patency of approximately 80 and 60% are
reported.22e24
The follow up after the procedure requires routine
annual colour-flow duplex scanning. This is a reliable,
patient friendly and cost effective procedure for diag-
nosing restenosis in the endarterectomized SFA.25
Primary patency of 45.8% was achieved with no re-
intervention at all. Only 33 radiological reinterven-
tions and 5 surgical reinterventions were considered
necessary, giving a primary assisted patency of
57.5%. Re-intervention was not required for all reste-
noses or all occlusions, because not all occlusions
resulted in limb ischemia. The decision to reintervene
was made on the basis of clinical symptoms or the
time interval between the USFAE and reocclusion.Our clinical experience showed that revision of early
(<1 year) recurrent stenoses improves the patency
rates. Late restenoses developing after two or three
years do not seem to progress to reocclusion and
may be treated conservatively. Ho et al. describe sim-
ilar results following RSFAE.26
In three prospective randomized studies, Green
et al., Johnson et al., and Burger et al. presented 5
year primary patency rates of prosthetic above-knee
bypass surgery, ranging from 38 to 45%.27e29 These
results are similar to the 5-year primary patency rates
of 45.8% of USFAE in our study. Smeets et al. pre-
sented the long-term results of remote endarterec-
tomy in long segment SFA occlusive disease in 164
patients. Their 5-year primary patency rate was
37.8%.15 Rosental et al. reported the medium-term
results of remote endarterectomy in long-segment
SFA occlusive disease with a 3-year patency rate of
61%. 30,31 However, these results have not been con-
firmed by all researchers. Indeed, Nelson et al. have
abandoned the RSFAE technique, because the 1-year
primary and primary-assisted patency rate were 40
and 59%, respectively.32 Devalia et al. reported pri-
mary and primaryeassisted patency rates at 5 years
following RSFAE of 16 and 60%, respectively. Based
on these data RSFAE cannot be recommended for
widespread use.33
USFAE is a minimally invasive procedure, having
the advantage of no synthetic vascular graft for poten-
tial infection. It creates less operative trauma and a
reduction of postoperative discomfort, leading to
earlier recovery and discharge of the patients asTable 3. Life table data of secondary patency rate
Interval start
time (years)
Number
entering
interval
Withdrawing
during interval
Number exposed
to risk
Number of
terminal events
Failure
rate, %
Cumulative
patency, %
Std. error
of cumulative
patency, %
0 218 15 210.5 12 5.7 94.3 1.6
1 191 17 182.5 15 8.2 86.5 2.4
2 159 17 150.5 19 12.6 75.6 3.2
3 123 25 110.5 9 8.1 69.5 3.5
4 89 35 71.5 4 5.6 65.6 3.8
5 50 50 25 0 0.0 65.6 3.8Eur J Vasc Endovasc Surg Vol 32, December 2006
662 A. V. Pokrovsky et al.described in other reports.34,35 Following failure of
USFAE other reconstruction techniques can still be
performed. The five year results of USFAE in a single
vascular surgery centre are presented here in order to
introduce the new SFA disobliteration method to
a wider circle of vascular surgeons. However, rando-
mised trials are required to establish theplace ofUSFAE
in the armamentarium of the vascular surgeon in the
treatment of long segmental SFA occlusive disease.
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